TRxADE HEALTH, Inc. (MEDS) Earning

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate

Company Earnings Date And Information

The company last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 1.56 M for the quarter and had revenue of 23.34 M for the year. The company has generated $-72 earnings per share over the last year ($-71.5 diluted earnings per share) and currently has a price-to-earnings ratio of -0.04. The company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.

Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/19/2026 Q1 2026 N/A -$3.70 N/A N/A $1.56 M
03/20/2026 Q4 2025 N/A -$13.50 N/A N/A $1.67 M
11/19/2025 Q3 2025 N/A -$23.00 N/A N/A $3.01 M
08/19/2025 Q2 2025 N/A -$5.50 N/A N/A $7.79 M
05/12/2025 Q1 2025 N/A -$31.00 N/A N/A $10.86 M
03/25/2025 Q4 2024 N/A -$4.17 N/A $2.54 M $-16,048,214
09/30/2024 Q3 2024 N/A -$1.80 N/A $2.48 M $15.80 M
06/30/2024 Q2 2024 N/A -$0.56 N/A $2.24 M $10.44 M
03/31/2024 Q1 2024 N/A -$1.82 N/A N/A $7.94 M
12/31/2023 Q4 2023 N/A -$12.60 N/A N/A $34.37 M
09/29/2023 Q3 2023 N/A -$0.87 N/A $2.28 M $0
06/29/2023 Q2 2023 N/A -$0.41 N/A $2.06 M $0

Earnings: FAQ's

The conference call for 's latest earnings report can be listened to online.

The conference call transcript for 's latest earnings report can be read online.

(:MEDS) has a recorded annual revenue of $23.34 M.

(:MEDS) has a recorded net income of $-101,274,530. has generated $-71.5 earnings per share over the last four quarters.

(:MEDS) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is 0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED